Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Top Stock Reports for Broadcom, Thermo Fisher & Aon

In This Article:

Thursday, February 20, 2025

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Broadcom Inc. (AVGO), Thermo Fisher Scientific Inc. (TMO) and Aon plc (AON), as well as a micro-cap stock, Massimo Group (MAMO).

These research reports have been hand-picked from roughly 70 reports published by our analyst team today. You can see all of today’s research reports here >>>

Ahead of Wall Street

The daily 'Ahead of Wall Street' article is a must-read for all investors who would like to be ready for that day's trading action. The article comes out before the market opens and attempts to make sense of that morning's economic releases and how they will affect that day's market action. You can read this article for free on our home page and can actually sign up there to get an email notification as this article comes out each morning.

You can read today's AWS here >>> Steady Jobless Claims, Good Philly Fed, Healthy Q4 Earnings

Today's Featured Research Reports

Broadcom’s shares have outperformed the Zacks Electronics - Semiconductors industry over the past year (+85.3% vs. +47.6%). The Zacks analyst believes that the company is benefiting from strong demand for its networking products and custom AI accelerators (XPUs). Broadcom’s expanding AI portfolio, along with a rich partner base, reflects solid top-line growth potential.

However, a challenging macroeconomic environment and high debt level are major concerns.

(You can read the full research report on Broadcom here >>>)

Thermo Fisher’s shares have underperformed the Zacks Medical – Instruments industry over the past year (-4.0% vs. +4.8%). The Zacks analyst believes that volatile macroeconomic uncertainties can dent Thermo Fisher’s operations. The continuous decline in COVID testing-related demand also adds to the worry.

Yet, the company is braving the ongoing tough economic conditions by utilizing the PPI Business System. Several recent product launches, including a Thermo Scientific Iliad scanning transmission electron microscope and new additions to the Gibco CTS Detachable Dynabeads platform have aided. Its continuous efforts to prioritize its partnership with customers to drive innovation and improve patient care bode well.

(You can read the full research report on Thermo Fisher here >>>)

Shares of Aon have outperformed the Zacks  Insurance – Brokerage industry over the past six months (+16.8% vs. +8.4%). Per the Zacks analyst, the company’s bottom line has been growing due to strategic initiatives and strong fundamentals, which have enhanced its capabilities and made it one of the largest insurance brokers.